Search details
1.
Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study.
Lancet Oncol
; 24(9): 1029-1041, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37657462
2.
Drug cost avoidance analysis of cancer clinical trials in Spain: a study on cost contributors and their impact.
BMC Health Serv Res
; 22(1): 948, 2022 Jul 26.
Article
in English
| MEDLINE | ID: mdl-35883128
3.
Analysis of adolescent oncology cases from 2008 through 2018 in a tertiary-level hospital: an opportunity for improvement.
Future Oncol
; 17(12): 1545-1551, 2021 Apr.
Article
in English
| MEDLINE | ID: mdl-33626935
4.
Immunoscore: a novel prognostic tool. Association with clinical outcome, response to treatment and survival in several malignancies.
Crit Rev Clin Lab Sci
; 57(7): 432-443, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32175789
5.
Sirt1 interaction with active Smad2 modulates transforming growth factor-ß regulated transcription.
Cell Commun Signal
; 15(1): 50, 2017 Nov 29.
Article
in English
| MEDLINE | ID: mdl-29187201
6.
Preventing alpelisib-related hyperglycaemia in HR+/HER2-/PIK3CA-mutated advanced breast cancer using metformin (METALLICA): a multicentre, open-label, single-arm, phase 2 trial.
EClinicalMedicine
; 71: 102520, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38638399
7.
Recurrent genetic variants and prioritization of variants of uncertain clinical significance associated with hereditary breast and ovarian cancer in families from the Region of Murcia.
Adv Lab Med
; 4(3): 279-287, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-38075165
8.
Next step in molecular genetics of hereditary breast/ovarian cancer: Multigene panel testing in clinical actionably genes and prioritization algorithms in the study of variants of uncertain significance.
Eur J Med Genet
; 65(4): 104468, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35245693
9.
Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study).
Lung Cancer
; 173: 83-93, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36162227
10.
SIRT1 and Estrogen Signaling Cooperation for Breast Cancer Onset and Progression.
Front Endocrinol (Lausanne)
; 9: 552, 2018.
Article
in English
| MEDLINE | ID: mdl-30319540
11.
New insights into the performance of multigene panel testing: Two novel nonsense variants in BRIP1 and TP53 in a young woman with breast cancer.
Cancer Genet
; 228-229: 1-4, 2018 12.
Article
in English
| MEDLINE | ID: mdl-30553462
12.
Variantes genéticas recurrentes y priorización de variantes de significado clínico desconocido asociadas al síndrome de cáncer de mama y ovario hereditario en familias de la Región de Murcia.
Adv Lab Med
; 4(3): 288-297, 2023 Sep.
Article
in Spanish
| MEDLINE | ID: mdl-38075173
13.
Mutational analysis of RAD51C and RAD51D genes in hereditary breast and ovarian cancer families from Murcia (southeastern Spain).
Eur J Med Genet
; 61(6): 355-361, 2018 Jun.
Article
in English
| MEDLINE | ID: mdl-29409816
14.
Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers.
Fam Cancer
; 16(4): 477-489, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28477318
15.
Potential drug-drug interactions in oncological adult inpatients at a Spanish hospital: epidemiology and risk factors.
Int J Clin Pharm
; 37(6): 1021-7, 2015 Dec.
Article
in English
| MEDLINE | ID: mdl-26391788
16.
[Primary non-lymphoid thymic neoplasms. A study of 58 cases]. / Neoplasias primarias del timo de estirpe no linfoide. Estudio de 58 casos.
Med Clin (Barc)
; 122(17): 664-7, 2004 May 08.
Article
in Spanish
| MEDLINE | ID: mdl-15153347
17.
Novel BRCA1 deleterious mutation (c.1918C>T) in familial breast and ovarian cancer syndrome who share a common ancestry.
Fam Cancer
; 13(3): 431-5, 2014 Sep.
Article
in English
| MEDLINE | ID: mdl-24633894
18.
[Immunohistochemical characterisation of breast cancer: towards a new clasification?]. / Características inmunohistoquímicas del cáncer de mama: hacia una nueva clasificación?
Cir Esp
; 84(3): 138-45, 2008 Sep.
Article
in Spanish
| MEDLINE | ID: mdl-18783672
19.
Características inmunohistoquímicas del cáncer de mama: ¿hacia una nueva clasificación? / Immunohistochemical characterisation of breast cancer: towards a new classification?
Cir. Esp. (Ed. impr.)
; 84(3): 138-145, sept. 2008. ilus, tab
Article
in Es
| IBECS (Spain) | ID: ibc-67763
Results
1 -
19
de 19
1
Next >
>>